| Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open … A Wang-Gillam, CP Li, G Bodoky, A Dean, YS Shan, G Jameson, ... The Lancet 387 (10018), 545-557, 2016 | 1295 | 2016 |
| A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma … JR Infante, BG Somer, JO Park, CP Li, ME Scheulen, SM Kasubhai, ... European journal of cancer 50 (12), 2072-2081, 2014 | 369 | 2014 |
| Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma E Van Cutsem, MA Tempero, D Sigal, DY Oh, N Fazio, T Macarulla, ... Journal of Clinical Oncology 38 (27), 3185-3194, 2020 | 356 | 2020 |
| Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study CP Li, Y Chao, KH Chi, WK Chan, HC Teng, RC Lee, FY Chang, SD Lee, ... International Journal of Radiation Oncology* Biology* Physics 57 (1), 98-104, 2003 | 289 | 2003 |
| High blood pressure and all-cause and cardiovascular disease mortalities in community-dwelling older adults CY Wu, HY Hu, YJ Chou, N Huang, YC Chou, CP Li Medicine 94 (47), e2160, 2015 | 244 | 2015 |
| Pulmonary tuberculosis increases the risk of lung cancer: a population‐based cohort study CY Wu, HY Hu, CY Pu, N Huang, HC Shen, CP Li, YJ Chou Cancer 117 (3), 618-624, 2011 | 237 | 2011 |
| Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma KH Chi, SJ Liu, CP Li, HP Kuo, YS Wang, Y Chao, SL Hsieh Journal of immunotherapy 28 (2), 129-135, 2005 | 234 | 2005 |
| Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma N Omura, CP Li, A Li, SM Hong, K Walter, A Jimeno, M Hidalgo, ... Cancer biology & therapy 7 (7), 1146-1156, 2008 | 202 | 2008 |
| The− 251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population WP Lee, DI Tai, KH Lan, AFY Li, HC Hsu, EJ Lin, YP Lin, ML Sheu, CP Li, ... Clinical Cancer Research 11 (18), 6431-6441, 2005 | 195 | 2005 |
| A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer JS Chen, C Hsu, NJ Chiang, CS Tsai, HH Tsou, SF Huang, LY Bai, ... Annals of oncology 26 (5), 943-949, 2015 | 148 | 2015 |
| Plasma interleukin-6 levels in patients with cirrhosis relationship to endotoxemia, tumor necrosis factor-α, and hyperdynamic circulation FY Lee, RH Lu, YT Tsai, HC Lin, MC Hou, CP Li, TM Liao, LF Lin, ... Scandinavian journal of gastroenterology 31 (5), 500-505, 1996 | 143 | 1996 |
| Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma SJ Hwang, JC Luo, CP Li, CW Chu, JC Wu, CR Lai, JH Chiang, GY Chau, ... World journal of gastroenterology: WJG 10 (17), 2472, 2004 | 142 | 2004 |
| Association of body mass index with all-cause and cardiovascular disease mortality in the elderly CY Wu, YC Chou, N Huang, YJ Chou, HY Hu, CP Li PloS one 9 (7), e102589, 2014 | 138 | 2014 |
| Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma A Lo, CP Li, EL Buza, R Blomberg, P Govindaraju, D Avery, J Monslow, ... JCI insight 2 (19), e92232, 2017 | 137 | 2017 |
| Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C CW Chu, SJ Hwang, JC Luo, CR Lai, SH Tsay, CP Li, JC Wu, FY Chang, ... Journal of Clinical Gastroenterology 32 (3), 240-244, 2001 | 132 | 2001 |
| Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial JP Wang, CY Wu, YC Yeh, YM Shyr, YY Wu, CY Kuo, YP Hung, MH Chen, ... Oncotarget 6 (20), 18162, 2015 | 131 | 2015 |
| Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. JC Luo, SJ Hwang, JC Wu, CR Lai, CP Li, FY Chang, JH Chiang, WY Lui, ... Hepato-gastroenterology 49 (47), 1315-1319, 2002 | 115 | 2002 |
| Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ... Journal of Clinical Oncology 41 (11), 2007-2019, 2023 | 113 | 2023 |
| Determinants of long-term care services among the elderly: a population-based study in Taiwan CY Wu, HY Hu, N Huang, YT Fang, YJ Chou, CP Li PLoS One 9 (2), e89213, 2014 | 107 | 2014 |
| Ruxolitinib+ capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies H Hurwitz, E Van Cutsem, J Bendell, M Hidalgo, CP Li, MG Salvo, ... Investigational new drugs 36, 683-695, 2018 | 104 | 2018 |
